Department of Musculoskeletal and Ageing Science, Institute of Life Course and Medical Sciences, Faculty of Health and Lifesciences, University of Liverpool, William Henry Duncan Building, 6 West Derby Street, Liverpool, L7 8TX, UK.
Division of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Oxford Road, Manchester, M13 9PT, UK.
BMC Vet Res. 2024 Oct 18;20(1):477. doi: 10.1186/s12917-024-04309-z.
Inherited and acquired muscle diseases are an important cause of morbidity and mortality in human medical and veterinary patients. Researchers use models to study skeletal muscle development and pathology, improve our understanding of disease pathogenesis and explore new treatment options. Experiments on laboratory animals, including murine and canine models, have led to huge advances in congenital myopathy and muscular dystrophy research that have translated into clinical treatment trials in human patients with these debilitating and often fatal conditions. Whilst animal experimentation has enabled many significant and impactful discoveries that otherwise may not have been possible, we have an ethical and moral, and in many countries also a legal, obligation to consider alternatives. This review discusses the models available as alternatives to mammals for muscle development, biology and disease research with a focus on inherited myopathies. Cell culture models can be used to replace animals for some applications: traditional monolayer cultures (for example, using the immortalised C2C12 cell line) are accessible, tractable and inexpensive but developmentally limited to immature myotube stages; more recently, developments in tissue engineering have led to three-dimensional cultures with improved differentiation capabilities. Advances in computer modelling and an improved understanding of pathogenetic mechanisms are likely to herald new models and opportunities for replacement. Where this is not possible, a 3Rs approach advocates partial replacement with the use of less sentient animals (including invertebrates (such as worms Caenorhabditis elegans and fruit flies Drosophila melanogaster) and embryonic stages of small vertebrates such as the zebrafish Danio rerio) alongside refinement of experimental design and improved research practices to reduce the numbers of animals used and the severity of their experience. An understanding of the advantages and disadvantages of potential models is essential for researchers to determine which can best facilitate answering a specific scientific question. Applying 3Rs principles to research not only improves animal welfare but generates high-quality, reproducible and reliable data with translational relevance to human and animal patients.
遗传性和获得性肌肉疾病是人类医学和兽医患者发病率和死亡率的重要原因。研究人员使用模型来研究骨骼肌肉发育和病理学,增进我们对疾病发病机制的理解,并探索新的治疗方法。实验室动物实验,包括鼠类和犬类模型,在先天性肌病和肌肉营养不良症的研究方面取得了巨大进展,这些进展已转化为人类患者的临床治疗试验,这些患者患有这些使人衰弱且常常致命的疾病。尽管动物实验使许多重要的、具有重大影响的发现成为可能,但我们有伦理、道德上的义务,而且在许多国家也有法律义务来考虑替代方案。本综述讨论了可替代哺乳动物用于肌肉发育、生物学和疾病研究的模型,重点是遗传性肌病。细胞培养模型可用于替代动物进行某些应用:传统的单层培养(例如,使用永生化的 C2C12 细胞系)易于获取、易于操作且成本低廉,但仅在不成熟的肌管阶段具有发育局限性;最近,组织工程的发展导致了具有改善分化能力的三维培养。计算机建模的进步和对发病机制的更好理解可能预示着新模型和替代机会的出现。在无法替代的情况下,3R 方法提倡使用较少有感知能力的动物(包括无脊椎动物(如秀丽隐杆线虫和黑腹果蝇)和小型脊椎动物的胚胎阶段,如斑马鱼 Danio rerio)进行部分替代,并改进实验设计和研究实践,以减少使用的动物数量及其体验的严重程度。研究人员必须了解潜在模型的优缺点,以确定哪种模型最适合回答特定的科学问题。将 3R 原则应用于研究不仅可以改善动物福利,还可以生成具有转化意义的高质量、可重复和可靠的数据,适用于人类和动物患者。